v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Jun. 30, 2024
Current assets    
Cash and cash equivalents $ 3,100 $ 10,442
Short-term investments 15,108 21,474
Accounts receivable 485 77
Inventory, net:    
Raw materials 2,194 2,038
Work-in-process 425 66
Finished goods 310 370
Prepaid expenses and other current assets 353 261
Total current assets 21,975 34,728
Property, Plant and Equipment, Net 2,395 2,763
Intangible assets, net 48 0
Operating lease assets 2,225 119
Other assets, net 346 30
Total assets 26,989 37,640
Liabilities, Current [Abstract]    
Accounts payable 1,066 373
Payroll related accruals 529 1,174
Accrued expenses and other liabilities 451 754
Operating and Finance Leases, Liability, Current 405 227
Total current liabilities 2,451 2,528
Accrued expenses and other liabilities, net of current portion 164 232
Operating and Finance Leases, Liability, Noncurrent 2,274 73
Total liabilities 4,889 2,833
Commitments and contingencies (Note 13)
Stockholders’ equity    
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at June 30, 2025 and 2024, respectively 0 0
Common stock, $0.001 par value, 250,000,000 shares authorized at June 30, 2025 and 2024 respectively; 1,769,269 and 1,712,045 shares issued at June 30, 2025 and 2024 respectively; 1,758,953 and 1,701,729 shares outstanding at June 30, 2025 and 2024, respectively 190,643 190,643
Treasury shares, 10,316 shares at June 30, 2025 and 2024, respectively (119) (119)
Additional paid-in capital 83,310 82,480
Accumulated deficit (250,870) (237,020)
Accumulated other comprehensive loss (864) (1,177)
Total stockholders’ equity 22,100 34,807
Total liabilities and stockholders’ equity $ 26,989 $ 37,640